Skip to main content
logo
Beauty Farm Medical and Health Industry Inc. (HKG:2373)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.42
+0.21 (1.09%)
Aug 12, 2026, 4:08 PM HKT

HKG:2373 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
317.56228.46215.66103.11193.48
Depreciation & Amortization
398.4377.24327.72293.81272.89
Other Amortization
6.345.344.023.432.3
Loss (Gain) From Sale of Assets
13.967.081.010.912.64
Asset Writedown & Restructuring Costs
----0.03
Loss (Gain) From Sale of Investments
-17.48-20.68-23.85-20.7-23.41
Loss (Gain) on Equity Investments
--0.05--
Stock-Based Compensation
16.76-0.3810.914.186.29
Provision & Write-off of Bad Debts
1.043.91-0.05-0.031.31
Other Operating Activities
78.8853.4455.1933.7740.63
Change in Accounts Receivable
22.6762.84-24.68-35.3-9.32
Change in Inventory
52.2156.3-47.95-46.36-31.73
Change in Accounts Payable
48.2-9.7445.76-26.3359.23
Change in Unearned Revenue
61.0850.8361.9161.54165.86
Change in Other Net Operating Assets
-0.54-18-0.17-0.03-10.25
Operating Cash Flow
999.09796.63625.51382669.93
Operating Cash Flow Growth
25.42%27.36%63.75%-42.98%-1.56%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-67.08-114.18-159.24-140.79-133.17
Sale of Property, Plant & Equipment
0.032.690.60.22-
Cash Acquisitions
-249.86-245.34-7.5-4.2-11.3
Divestitures
10.08--2.133.66
Investment in Securities
-99.46-4.13-551.11200.52-244.54
Other Investing Activities
18.9420.046.06--
Investing Cash Flow
-396.42-340.85-711.1953.63-385.35

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
614.04157.5---
Long-Term Debt Repaid
-304.42-273.43-232.08-231.43-183.87
Net Debt Issued (Repaid)
309.62-115.93-232.08-231.43-183.87
Issuance of Common Stock
--506.553.9818.33
Repurchase of Common Stock
-24.89--12.01--
Common Dividends Paid
-122.27-112.49-87-204.26-81.16
Other Financing Activities
-110.685.06-41.72-1.1-24.36
Financing Cash Flow
51.79-223.36133.74-432.82-271.07

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.75-0.5312.094.030.23
Net Cash Flow
653.71231.8860.166.8413.75

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
932.01682.44466.27241.21536.76
Free Cash Flow Growth
36.57%46.36%93.31%-55.06%-12.44%
Free Cash Flow Margin
31.06%26.53%21.74%14.75%30.14%
Free Cash Flow Per Share
4.022.972.031.212.69
Levered Free Cash Flow
767.661,067435.97196.28503.06
Unlevered Free Cash Flow
787.761,084451.48211.73518.2

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.122.88--0.02
Cash Income Tax Paid
57.6242.4628.1927.0945.93
Change in Working Capital
183.62142.2334.87-46.48173.78